CIK 1009258
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.84% | 48 |
| Health Care Providers & Services | 9.32% | 7 |
| Unclassified | 5.20% | 7 |
| Health Care Equipment & Supplies | 3.44% | 6 |
| Insurance | 2.70% | 2 |
| Life Sciences Tools & Services | 0.88% | 1 |
| Software | 0.62% | 1 |
| Technology Hardware & Equipment | 0.00% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | NUVL | Nuvalent, Inc. | Health Care | 24.62% |
| 2 | COGT | Cogent Biosciences, Inc. | Health Care | 4.85% |
| 3 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 4.32% |
| 4 | VTRS | Viatris Inc | Health Care | 3.80% |
| 5 | UTHR | UNITED THERAPEUTICS Corp | Health Care | 3.78% |
| 6 | RVMD | Revolution Medicines, Inc. | Health Care | 3.11% |
| 7 | CELC | Celcuity Inc. | Health Care | 2.73% |
| 8 | CNC | CENTENE CORP | Financials | 2.70% |
| 9 | LRMR | Larimar Therapeutics, Inc. | Health Care | 2.23% |
| 10 | BKD | Brookdale Senior Living Inc. | Health Care | 2.22% |
66/73 names classified · sector 94.8% of weight · industry 94.8% · mkt cap 91.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 17% of book weight classified — the grid is NOT representative of the whole book.
Classified: 16.9% of book weight (17/72 names) · unclassified 83.1%: NUVL, COGT, PRAX, VTRS, RVMD, CELC, CNC, LRMR, BKD, VERA +45 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 17,248,450 | $1.8B | 24.6% | HOLD |
| 2 | COGTCOGENT BIOSCIENCES INC | 9,043,903 | $348M | 4.9% | HOLD |
| 3 | PRAXPRAXIS PRECISION MEDICINES I | 963,351 | $310M | 4.3% | ADD 7% |
| 4 | VTRSVIATRIS INC | 20,206,170 | $273M | 3.8% | HOLD |
| 5 | UTHRUnited Therapeutics Corp. | 457,000 | $271M | 3.8% | ADD 7% |
| 6 | RVMDREVOLUTION MEDICINES INC | 2,297,000 | $223M | 3.1% | TRIM −21% |
| 7 | CELCCELCUITY INC | 1,714,000 | $196M | 2.7% | HOLD |
| 8 | CNCCENTENE CORP DEL | 5,917,091 | $194M | 2.7% | TRIM −8% |
| 9 | LRMRLARIMAR THERAPEUTICS INC | 35,606,974 | $160M | 2.2% | ADD 16% |
| 10 | BKDBROOKDALE SR LIVING INC | 11,637,032 | $159M | 2.2% | HOLD |
| 11 | VERAVERA THERAPEUTICS INC | 3,722,100 | $150M | 2.1% | TRIM −8% |
| 12 | IONSIONIS PHARMACEUTICALS INC | 1,979,669 | $149M | 2.1% | HOLD |
| 13 | BCRXBIOCRYST PHARMACEUTICALS INC | 15,038,000 | $143M | 2.0% | ADD 5% |
| 14 | INSPINSPIRE MED SYS INC | 2,703,238 | $139M | 1.9% | ADD 80% |
| 15 | LEGNLEGEND BIOTECH CORP | 7,687,638 | $139M | 1.9% | ADD 30% |
| 16 | AHCOADAPTHEALTH CORP | 11,477,730 | $137M | 1.9% | HOLD |
| 17 | NAMSNEWAMSTERDAM PHARMA COMPANY | 4,264,789 | $137M | 1.9% | ADD 2% |
| 18 | ACHCACADIA HEALTHCARE COMPANY IN | 4,520,000 | $106M | 1.5% | HOLD |
| 19 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,573,297 | $99M | 1.4% | TRIM −14% |
| 20 | CPRXCATALYST PHARMACEUTICALS INC | 3,943,600 | $98M | 1.4% | TRIM −20% |
| 21 | INDVINDIVIOR PHARMACEUTICALS INC COM | 3,097,790 | $94M | 1.3% | NEW |
| 22 | XENEXENON PHARMACEUTICALS INC | 1,615,696 | $94M | 1.3% | ADD 198% |
| 23 | PHVSPHARVARIS N V | 3,126,042 | $88M | 1.2% | HOLD |
| 24 | SNDXSYNDAX PHARMACEUTICALS INC | 3,779,900 | $88M | 1.2% | NEW |
| 25 | TNGXTANGO THERAPEUTICS INC | 4,146,813 | $87M | 1.2% | ADD 43% |
| 26 | DNTHDIANTHUS THERAPEUTICS INC | 1,019,813 | $86M | 1.2% | NEW |
| 27 | PFEPFIZER INC | 3,040,000 | $85M | 1.2% | NEW |
| 28 | NBIXNEUROCRINE BIOSCIENCES INC | 610,000 | $80M | 1.1% | TRIM −48% |
| 29 | DAY ONE BIOPHARMACEUTICALS I | 3,723,131 | $80M | 1.1% | HOLD |
| 30 | SVRASAVARA INC | 13,569,000 | $74M | 1.0% | HOLD |
| 31 | ENHABIT INC | 4,747,746 | $67M | 0.9% | HOLD |
| 32 | GMABGENMAB A/S | 2,462,000 | $66M | 0.9% | NEW |
| 33 | BIOBIO RAD LABS INC | 226,070 | $63M | 0.9% | HOLD |
| 34 | LNTHLANTHEUS HLDGS INC | 827,999 | $63M | 0.9% | HOLD |
| 35 | SPRYARS PHARMACEUTICALS INC | 7,503,812 | $60M | 0.8% | HOLD |
| 36 | STOKSTOKE THERAPEUTICS INC | 1,823,500 | $59M | 0.8% | HOLD |
| 37 | NVSTENVISTA HOLDINGS CORPORATION | 2,210,100 | $56M | 0.8% | TRIM −3% |
| 38 | IDYAIDEAYA BIOSCIENCES INC | 1,530,008 | $51M | 0.7% | TRIM −29% |
| 39 | BLTEBELITE BIO INC | 304,013 | $48M | 0.7% | ADD 30% |
| 40 | BMRNBIOMARIN PHARMACEUTICAL INC | 851,556 | $48M | 0.7% | NEW |
| 41 | KYMRKYMERA THERAPEUTICS INC | 561,170 | $47M | 0.7% | HOLD |
| 42 | CERTCERTARA INC | 7,808,605 | $45M | 0.6% | HOLD |
| 43 | BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | 4,885,446 | $44M | 0.6% | HOLD |
| 44 | IRONDISC MEDICINE INC | 657,000 | $42M | 0.6% | ADD 29% |
| 45 | SIONSIONNA THERAPEUTICS INC | 970,590 | $39M | 0.5% | HOLD |
| 46 | CDNACAREDX INC | 2,191,000 | $38M | 0.5% | HOLD |
| 47 | GPCRSTRUCTURE THERAPEUTICS INC | 767,993 | $37M | 0.5% | HOLD |
| 48 | VCYTVERACYTE INC | 726,000 | $23M | 0.3% | HOLD |
| 49 | ALNYALNYLAM PHARMACEUTICALS INC | 67,935 | $22M | 0.3% | HOLD |
| 50 | EMBCEMBECTA CORP | 2,534,961 | $22M | 0.3% | TRIM −8% |
| 51 | TYRATYRA BIOSCIENCES INC | 549,000 | $21M | 0.3% | NEW |
| 52 | FHTXFOGHORN THERAPEUTICS INC | 4,394,367 | $21M | 0.3% | ADD 20% |
| 53 | DRUGBRIGHT MINDS BIOSCIENCES INC | 283,000 | $21M | 0.3% | NEW |
| 54 | CMPXCOMPASS THERAPEUTICS INC | 3,606,000 | $19M | 0.3% | HOLD |
| 55 | MNPRMONOPAR THERAPEUTICS INC | 323,745 | $18M | 0.2% | ADD 90% |
| 56 | KYTXKYVERNA THERAPEUTICS INC | 2,000,000 | $17M | 0.2% | HOLD |
| 57 | SGPSPYGLASS PHARMA INC | 550,000 | $14M | 0.2% | NEW |
| 58 | BBNXBETA BIONICS INC | 1,324,000 | $13M | 0.2% | ADD 41% |
| 59 | TSHATAYSHA GENE THERAPIES INC | 2,722,165 | $12M | 0.2% | HOLD |
| 60 | TOITHE ONCOLOGY INSTITUTE INC | 3,360,052 | $10M | 0.1% | HOLD |
| 61 | CGEMCULLINAN THERAPEUTICS INC | 386,169 | $5M | 0.1% | HOLD |
| 62 | ANNXANNEXON INC | 583,913 | $3M | 0.0% | HOLD |
| 63 | ALECALECTOR INC | 1,055,192 | $2M | 0.0% | HOLD |
| 64 | NAMSWNEWAMSTERDAM PHARMA CO NV-27 | 92,787 | $2M | 0.0% | HOLD |
| 65 | EWEDWARDS LIFESCIENCES CORP | 13,702 | $1M | 0.0% | HOLD |
| 66 | PHGEBIOMX INC | 131,272 | $492,795 | 0.0% | HOLD |
| 67 | MANEVeradermics Inc | 5,000 | $315,750 | 0.0% | NEW |
| 68 | HUMHUMANA INC | 917 | $158,999 | 0.0% | HOLD |
| 69 | TOIIWTHE ONCOLOGY INSTITUTE INC | 1,250,000 | $54,750 | 0.0% | HOLD |
| 70 | QSIQUANTUM SI INC | 333,333 | $36,200 | 0.0% | HOLD |
| 71 | PMVPPMV PHARMACEUTICALS INC | 8,790 | $10,900 | 0.0% | HOLD |
| 72 | SRZNWSURROZEN INC | 166,666 | $2,667 | 0.0% | HOLD |
| 73 | MYGNMYRIAD GENETICS INC | 505 | $2,273 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| NUVLNUVALENT INC | 18.0M | 18.0M | 18.0M | 18.0M | 17.2M | 17.2M | $1.8B |
| COGTCOGENT BIOSCIENCES INC | 2.6M | 2.6M | 2.6M | 9.1M | 9.0M | 9.0M | $348M |
| PRAXPRAXIS PRECISION MEDICINES I | — | 620K | 687K | 841K | 903K | 963K | $310M |
| VTRSVIATRIS INC | 24.0M | 24.0M | 24.0M | 24.1M | 20.2M | 20.2M | $273M |
| UTHRUnited Therapeutics Corp. | — | 275K | 541K | 426K | 426K | 457K | $271M |
| RVMDREVOLUTION MEDICINES INC | 3.3M | 3.3M | 3.4M | 3.7M | 2.9M | 2.3M | $223M |
| CELCCELCUITY INC | — | — | — | 734K | 1.7M | 1.7M | $196M |
| CNCCENTENE CORP DEL | 2.7M | 2.7M | 3.2M | 9.0M | 6.4M | 5.9M | $194M |
| LRMRLARIMAR THERAPEUTICS INC | 21.2M | 21.2M | 21.2M | 30.6M | 30.6M | 35.6M | $160M |
| BKDBROOKDALE SR LIVING INC | 15.6M | 15.6M | 15.4M | 11.6M | 11.6M | 11.6M | $159M |
| VERAVERA THERAPEUTICS INC | — | 1.1M | 3.3M | 3.6M | 4.1M | 3.7M | $150M |
| IONSIONIS PHARMACEUTICALS INC | — | — | — | 2.0M | 2.0M | 2.0M | $149M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 8.1M | 5.2M | 4.7M | 12.2M | 14.3M | 15.0M | $143M |
| INSPINSPIRE MED SYS INC | — | — | 140K | 1.0M | 1.5M | 2.7M | $139M |
| LEGNLEGEND BIOTECH CORP | 1.6M | 1.7M | 3.0M | 3.0M | 5.9M | 7.7M | $139M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
